Related Experiment Videos
Mutations associated with beta-thalassemia intermedia in Kuwait.
Adekunle Adekile1, Mohammad Haider, Ferdane Kutlar
1Department of Pediatrics, Faculty of Medicine, Kuwait University, Kuwait. adekile@hsc.edu.kw
Summary
Two common beta-globin gene mutations, IVS-I-II and IVS-I-6, are frequently linked to beta-thalassemia intermedia in Kuwait. Early identification of these genetic factors is crucial for effective patient management.
Area of Science:
- Genetics
- Hematology
Background:
- Beta-thalassemia intermedia is a genetic blood disorder.
- Identifying specific gene mutations aids in understanding disease severity and management.
Purpose of the Study:
- To identify beta-globin gene mutations causing beta-thalassemia intermedia in Kuwait.
- To correlate specific genotypes with clinical presentation in Kuwaiti patients.
Main Methods:
- Studied 18 patients from 13 unrelated families with beta-thalassemia intermedia.
- Utilized complete blood count, hemoglobin quantitation, PCR, allele-specific oligonucleotide hybridization, and DNA sequencing.
- Screened for alpha2-globin gene deletion (-3.7 kb).
Main Results:
- Identified several beta-globin gene mutations including IVS-I-II (G-->A) and IVS-I-6 (T-->C).
- Homozygosity for IVS-II-1 and IVS-I-6 mutations accounted for 61% of genotypes.
- Compound heterozygous mutations were also identified.
Conclusions:
- The IVS-I-II and IVS-I-6 mutations are common in Kuwaiti beta-thalassemia intermedia patients.
- Early genetic screening for these mutations can prevent unnecessary treatments like hypertransfusion.